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Abstract
Background: Albuminuria is a marker of glomerular damage in Sickle Cell Disease (SCD). In this study, we sought to
determine the possible predictors of albuminuria in the two more prevalent genotypes of SCD among the Jamaica Sickle
Cell Cohort Study participants.
Methods: An age-matched cohort of 122 patients with HbSS or HbSC genotypes had measurements of their morning urine
albumin concentration, blood pressure, body mass index, haematology and certain biochemistry parameters done.
Associations of albuminuria with possible predictors including hematological parameters, reticulocyte counts, aspartate
aminotransferase (AST) and lactate dehydrogenase (LDH) levels were examined using multiple regression models.
Results: A total of 122 participants were recruited (mean age 28.6 years 62.5 years; 85 HbSS, 37 HbSC). 25.9% with HbSS
and 10.8% with HbSC disease had microalbuminuria (urine albumin/creatinine ratio = 30–300 mg/g of creatinine) whereas
16.5% of HbSS and 2.7% of HbSC disease had macroalbuminuria (urine albumin/creatinine ratio.300 mg/g of creatinine).
Mean arterial pressure, hemoglobin levels, serum creatinine, reticulocyte counts and white blood cell counts were
statistically significant predictors of albuminuria in HbSS, whereas white blood cell counts and serum creatinine predicted
albuminuria in HbSC disease. Both markers of chronic hemolysis, i.e. AST and LDH levels, showed no associations with
albuminuria in either genotype.
Conclusions: Renal disease, as evidenced by excretion of increased amounts of albumin in urine due to a glomerulopathy, is
a common end-organ complication in SCD. It is shown to be more severe in those with HbSS disease than in HbSC disease.
Rising blood pressure, lower hemoglobin levels and higher white blood cell counts are hints to the clinician of impending
renal disease, whereas higher rates of hemolysis do not appear to play a role in this complication of SCD.
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Introduction
Chronic renal failure is common in the Jamaican population
with a prevalence of 327 per million persons [1]. Sickle cell disease
(SCD) is the commonest hemoglobinopathy in Jamaica with an
incidence of 1:150 live births. Renal failure in turn is also common
among subjects with SCD, and constitutes ,1% of the cases of
renal dysfunction in the island [1]. Renal failure has contributed to
about 18% of death in Jamaican patients over 40 years of age with
the homozygous SS (HbSS) disease [2]. As improved clinical
management of patients reflects into longer life span, renal failure
will play an increasing role in their morbidity and mortality. Once
end-stage renal disease is diagnosed, survival thereafter is limited
to about 4 years [3].
Proteinuria is known to be a frequent finding in SCD [4], and
albuminuria may infact be an early marker of glomerular disease
leading ultimately to renal failure [5]. In general, there is evidence
suggesting that proteinuria itself may induce further nephrotox-
icity [6,7]. In SCD, major determinants of the prevalence of
proteinuria are age and genotype. In general the prevalence of
proteinuria increases with age and is higher in HbSS compared
with heterozygous SC (HbSC) genotype [3,8]. Microalbuminuria
has been reported in 6.2% of pediatric patients with HbSS; but
10% in teenagers with HbSS [9]. In adults, the prevalence rises to
17–49% of those with HbSS [10,11]. The clinical relevance and
the pathogenic mechanisms underlying albuminuria in SCD are
unclear but increased glomerular filtration rate (GFR) and renal
plasma flows are noted in early years [12,13]. It has been proposed
that this hyper-filtration leads to gradual sclerosis of the
glomerular capillaries and predisposes to renal insufficiency in
these patients [12,14]. Also the use of angiotensin converting
enzyme (ACE) inhibitors, which reduces glomerular hyperfiltra-
tion, has been reported to be effective in reducing proteinuria in
sickle cell disease [11,15,16]. Within this context, screening,
assessment for possible renal damage and identification of
modifiable risks factors could help improve outcome. In this
study, we sought to determine the prevalence of albuminuria in
patients with HbSS and HbSC from the Jamaica Sickle Cell
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particular the association of albuminuria with increasing rates of
hemolysis.
Methods
A descriptive, observational, cross- sectional study was per-
formed at the Sickle Cell Unit (SCU) of the Tropical Medicine
Research Institute, The University of the West Indies from
January - February 2006.
Ethics Statement
The study was granted ethical approval by the University of the
West Indies/University Hospital of the West Indies Ethical
Committee. The study was designed and performed in adherence
with the Declaration of Helsinki. Written, informed consent was
obtained from all participants involved in the study.
Participants
These patients have attended the SCU and have participated in
the JSCCS since birth [17]. At the 2006 annual review, 122
patients with HbSS or HbSC were studied. Inclusion criteria
included a mid stream urine test negative for infection, and none
were presently on angiotensin converting enzyme inhibitor (ACE
inhibitor) or angiotensin receptor blocker (ARB) therapy. All
participants were clinically healthy at the time of the study.
Measurements
The participants had measurements of their morning urine
albumin concentration using an immunoturbidimetric assay on
Alcyon
TM 300 Falcor. Three measurements of sitting blood
pressure and pulse rate were taken at 5-minute intervals using a
DynamapH. The averages of the three determinations were used in
the study. Mean arterial pressure was calculated from the mean
systolic and diastolic blood pressure values as [1/3(Systolic
pressure) + 2/3(Diastolic pressure)].
Height was measured with a wall- mounted Staidiometer and
weight was measured using a lever balance.
Blood samples were collected from each subject for various
hematological and biochemical measurements and stored at
270uC until analysis was done.
Statistical Analysis
Descriptive statistics e.g. means, standard deviations and
frequency counts were used as appropriate. We used two sample
t-tests to test for differences between means in continuous outcome
measurements by genotype.
Random urine albumin values were left censored at ,4.0 mg/L
as this represented the lower limits of detection for the albumin
assay. Fifty seven (47%) observations were censored and for them,
we set the value of albumin concentration to 2.0 (4.0/2) mg/L.
Albumin- creatinine ratios (ACR) were calculated using this value
for albumin concentrations. Microalbuminuria was defined as
ACR 30–300 mg/g of creatinine, and macroalbuminuria as
.300 mg/g of creatinine. As the distribution of the ACR was
right skewed, it was normalized using log transformation. To
determine the predictors of albuminuria, a series of multiple linear
regressions with log ACR as outcome were performed. The
potential predictors included hematology, anthropometry, blood
pressure, age, and gender. Predictors of albuminuria were selected
using a manual procedure after adjusting for gender. Models were
compared using the partial F statistic. As the distributions of
hematological variables were different by genotype, regressions
models incorporating these variables were performed separately by
genotype. Significance was defined at an alpha level of 0.05.
Data was analyzed using Stata Software version 10.0 for
Windows
TM (StataCorp, College Station, TX).
Results
A total of 122 participants were included in the study. Of these,
69.7% (50 males, 35 females) were of HbSS genotype and 30.3%
(22 males, 15 females) were HbSC. The mean age of the sample
was 28.6 +/2 2.5 years with a range from 24.1–32.5 years. There
was no statistical significant difference in age between the two
genotypes.
General characteristics
There were statistically significant differences between all the
potential predictor variables by genotype with the exception of age,
height, systolic blood pressure and serum iron. HbSS patients had
lower weight, BMI, diastolic blood pressure, mean arterial pressure,
hemoglobin, lower sodium and serum creatinine than their HbSC
counterparts. However, they had higher fetal hemoglobin, absolute
reticulocyte counts, white blood cell counts, lactate dehydrogenase
(LDH) and aspartate aminotransferase (AST) (the last two as a
markers of hemolysis) (Table 1). Almost 29% of this group of HbSS
patients had a lifetime history of having had chronic leg ulceration,
i.e. a leg ulcer lasting 6 months or longer. Majority (56.5%) of our
HbSS sample had the normal complement of a genes (aa/aa)
whereas 40% had a single a gene deletion, i.e. heterozygous a-
thallassemia (aa/a-). The data on leg ulcer prevalence and a gene
status was not available for the HbSC sample.
Urinary albumin excretion
HbSS patients had significantly higher urinary albumin/
creatinine ratios than those with HbSC disease (Figure 1).
Microalbuminuria was found in 25.9% of patients with HbSS,
as compared to 10.8% of those with HbSC disease, whereas
macroalbuminuria was present in 16.5% of HbSS and 2.7% of
HbSC patients. Within HbSS, those with a history of chronic leg
ulceration had a significantly higher prevalence of albuminuria
(40% albuminuria vs. 20% albuminuria, p value: 0.05), whereas
there was no difference in albuminuria by a gene status (Table 2).
Factors associated with albuminuria
The distribution of the hematological variables by genotype was
distinct, i.e. overlap was minimal. Hence separate multiple linear
regression analyses were performed for each genotype to facilitate
inclusion of these variables. For persons with HbSS, higher mean
arterial pressure (p value ,0.001), higher white blood cell counts
(p value 0.003), lower hemoglobin (p value 0.03), lower absolute
reticulocyte counts (p value 0.02) and lower serum creatinine (p
value 0.04) were significant predictors of higher albumin
excretions in the urine (Table 3). This model accounted for
almost 33% of the variance observed in the outcome.
For persons with HbSC, higher white blood cell counts (p value
0.013) and higher serum creatinine levels (p value 0.02) predicted
greater levels of albuminuria (Table 4). This model accounted for
about 33.5% of the variance observed in the outcome. Gender,
blood pressure and hemoglobin levels were not seen to be
significant predictors in this genotype.
Discussion
In this study, albuminuria was present in 42.3% of HbSS and
13.5% of HbSC patients. This compares quite well to past studies
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scant and have reported levels of 9% (1 out of 11 patients studied)
[18]. The present study is especially important as it offers a view of
renal dysfunction in a cohort of patients with SCD which has been
actively followed up since birth. In fact, the same cohort of HbSS
patients had albuminuria levels measured at 26% ten years before
this study [19] indicating a worsening glomerulopathy. Hemoglo-
bin is once again shown to be negatively associated with
albuminuria in those with HbSS, as it was in the study 10 years
ago, even though Guasch et al. have shown nil relation of
hemoglobin with albuminuria. They did however show signifi-
cantly lower levels of hemoglobin once their patients had overt
renal insufficiency [20]. Undoubtedly, proteinuria, increasing
blood pressures and worsening anemia have been shown to
precede overt renal failure in persons with HbSS in past studies
[3].
Mean arterial pressure is seen to be associated with increasing
albuminuria in persons with HbSS. Higher blood pressures have
been shown to be associated with increased mortality [21], and
one mechanism may be through renal dysfunction. The study by
Powars et al. [3] has shown that whereas higher blood pressures
accompanied (and in fact preceded chronic renal failure) all those
who had renal failure, none of their controls (those without renal
failure) had high blood pressure. It is important therefore clinically
to be alert to rising blood pressure values, even to levels that are
normal in those without SCD, as they will usually signify
impending renal insufficiency.
LDH is known to be a marker of increasing severity in SCD and
there are strong epidemiological associations between its elevation
and both endothelial activation and pulmonary hypertension [22].
Data suggest that high LDH values may predict early mortality.
However, neither LDH nor AST levels (both of which indicate
hemolysis) have shown any association with albuminuria for either
Table 1. Summary of anthropometry, hematology, biochemistry and blood pressure characteristics by genotype.
SS (n=85) SC (n=37)
Mean SD Mean SD P-value 95% Confidence Interval
Age (years) 28.5 2.6 28.9 2.5 0.38 20.6 to 1.4
Height (cm) 170.0 8.4 169.5 8.6 0.75 23.8 to 2.8
Weight (Kg) 57.7 10.1 67.0 14.6 ,0.001 4.7 to 13.8
BMI (Kg/m
2) 20.0 3.0 23.2 4.4 ,0.001 2.0 to 4.6
Systolic BP (mm Hg) 108.0 11.2 107.6 11.2 0.86 24.8 to 4.0
Diastolic BP (mm Hg) 62.5 11.2 70.0 9.8 ,0.001 3.3 to 11.7
Mean arterial pressure (mmHg) 77.8 10.4 82.5 9.3 0.02 0.78 to 8.7
Fetal hemoglobin (%) 4.7 3.5 2.0 2.3 ,0.001 24.0 to 21.5
Hemoglobin (g/dL) 8.2 1.4 12.3 1.5 ,0.001 3.5 to 4.6
Absolute Retics (10
6/L) 364.5 212.9 263.3 118.1 0.009 2176.1 to 226.3
White blood cells (610
9/L) 11.0 3.9 7.7 3.0 ,0.001 24.8 to 21.9
Lactate dehydrogenase (U/L) 404.0 143.6 225.6 63.8 ,0.001 2227.2 to 2130.0
Serum creatinine (mmol/L) 53.0 14.3 72.7 14.4 ,0.001 14.2 to 25.4
Sodium (mmol/L) 132.4 10.1 136.5 5.9 0.02 0.56 to 7.8
Serum Iron 12.8 5.1 11.8 3.7 0.29 22.9 to 0.9
Aspartate Aminotransferase (U/L) 39.2 17.8 22.0 6.9 ,0.001 223.8 to 210.6
doi:10.1371/journal.pone.0018863.t001
Figure 1. Albumin/creatinine ratios with SDs for SS and SC
genotypes. Values are geometric means with 95% confidence
intervals.
doi:10.1371/journal.pone.0018863.g001
Table 2. Prevalence of Leg Ulceration and a-Thal trait vs.
albuminuria status in SS genotype.
Albuminuria Status p-value
Positive Negative
Leg Ulceration, n(%)
Yes
No
14 (40.0)
21 (60.0)
10 (20.4)
39 (79.6)
0.050
a-Thal Status, n(%)
a -/a –
a -/aa
aa/aa
1 (2.8)
12 (33.3)
23 (63.9)
2 (4.1)
22 (44.9)
25 (51.0)
0.496
doi:10.1371/journal.pone.0018863.t002
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pulmonary hypertension and sickle nephropathy may be different.
Guasch et al. [20] have also reported no association between LDH
and albuminuria, whereas Taylor et al. [23] have reported no
association of LDH with glomerular filtration rates. On the other
hand Gurkan et al. [24] have reported a significant association of
albuminuria with LDH and Maier-Redelsperger and colleagues
[25] have found a composite variable, composed of LDH and
reticulocytes, to be highly correlated to albuminuria.
We are further reporting that absolute reticulocyte counts are
significant negative predictors of albuminuria in those with HbSS
disease. This is contrary to the findings of Guasch et al. who
reported no association of reticulocytes with albuminuria. They
however conducted their analyses using percentage of reticulocytes
which may not necessarily indicate reticulocytosis. Haymann et al.
[26] have in their study demonstrated a positive relationship
between glomerular filtration rate and reticulocyte counts.
Similarly, Maier-Redelsperger et al. [25] have reported lower
log(RBC-Hb/Ret-Hb) values, a marker of red cell survival in those
with albuminuria. The relationship between albuminuria and
reticulocytosis will be confounded by measurement techniques, red
cell survival as well as variations in marrow activity. Our findings
may suggest lower marrow activity in those with decreasing renal
function, possibly mediated by decreasing erythropoietin levels.
White blood cell count is also known to be a marker of severity
in SCD and is a strong predictor of mortality [27]. This study has
shown it to be associated with increasing albuminuria in both
genotypes indicating a possible inflammatory mechanism that is
implicated in the pathogenesis of sickle nephropathy. It is well
known that part of the pathogenesis of vascular occlusion in SCD
is due to increased leukocyte adherence to its endothelium [28].
Asymptomatic bacteriuria has been shown to be higher in SCD
[29] with a prevalence of 5% in this study cohort, and its
association with subsequent nephropathy remains to be deter-
mined; however, the presence of subclinical infections associated
with high leukocyte counts may be one mechanism behind sickle
nephropathy. The decrease in neutrophils secondary to hydroxy-
urea therapy may therefore be a beneficial therapy in slowing
progression of nephropathy, especially as it has been that those
with high leukocyte count tend to show a greater positive response
to hydroxyurea therapy [30].
In summary, even though the cross-sectional design of this study
does not allow for causal inferences to be drawn, patients with
rising blood pressure, higher white blood cell counts and those
with HbSS may be more prone to renal dysfunction and an early
marker of disease is albuminuria. Prospective studies are needed to
establish a causal relationship as regular screening may then help
identify renal disease early and timely interventions may help
delay the progression of nephropathy.
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